Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 * "2+10" Design

Jan.07
Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 * "2+10" Design
UK introduces new Bloody Bar 30K Triple Twist e-cigarette with unique pod design and multiple flavor options.

Special announcement:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are for descriptive purposes only and are not intended as advertisements for any products.

This article is prohibited for minors to access.


 

UK e-cigarette market have launched a new e-cigarette - the Bloody Bar 30K Triple Twist. This product features a unique design that combines 3 "2+10" combinations, offering triple flavors and 30,000 puffs.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Translation: Bloody Bar 30K Triple Twist|Image source: goldenvape

 

 

Specifically, the product specifications of the Bloody Bar 30K Triple Twist are as shown in the table below.

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Bloody Bar 30K Triple Twist Parameters | Design: 2Firsts

The key feature of the Bloody Bar 30K Triple Twist is its unique pod design. This e-cigarette device comes with three "2+10" pods, each with a total e-liquid capacity of 36 milliliters. Additionally, each pod can be filled with a different e-liquid flavor, allowing for quick flavor changes through a rotating mechanism.

 

Previously, Bloody Bar released a 2-in-1 e-cigarette called the Bloody Bar Ultra Twist 20K, which is capable of providing two different flavors at the same time. Users can easily switch between flavors by rotating the mouthpiece.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Public Notice | Image Source: MHRA

 

It is worth noting that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) e-cigarette notification system shows that "BLOODY BAR TRIPLE TWIST 30K" was publicly announced in November 2024. The applicant is BOWMAN SPECIALISED LIQUIDS LIMITED, founded by Christopher Bowman in 2012, a company focused on research and sales of e-cigarette e-liquids.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
BOWMAN SPECIALISED LIQUIDS LIMITED Website | Image source: BOWMAN

 

Currently, the Bloody Bar 30K Triple Twist has been listed on various UK e-cigarette distributor websites such as vapesourcing, ecigone, and vapeuk, with a price of approximately £12.99. However, the product has not yet been made available for sale on the company's official website.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Blood Bar 30K Triple Twist | Image source: vapesourcing

 


2Firsts will continue to monitor the performance and market trends of e-cigarette products globally, providing accurate and authoritative industry information to the public.

 

2FIRSTS, a product column, is dedicated to providing readers with the latest information on new products in the tobacco industry. To gather and share first-hand industry information more widely, 2FIRSTS welcomes readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us anytime via email at info@2firsts.com.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
British American Tobacco has paused the U.S. pilot launch of its unlicensed Vuse One vape amid intensified FDA enforcement.
Oct.28 by 2FIRSTS.ai
RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%
RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%
RLX Technology Inc. (NYSE: RLX) announced its unaudited financial results for the third quarter of 2025. The company reported net revenue of RMB 1.13 billion, up 49.3% year-on-year, and adjusted net profit of RMB 295.4 million, up 1.4% quarter-on-quarter. International business contributed 72% of total revenue, reflecting robust financial performance and continued shareholder returns.
Nov.14
Smoore’s Q3 Revenue Hits Record High, Reflecting Structural Growth in Global HNB and E-Vapor Markets
Smoore’s Q3 Revenue Hits Record High, Reflecting Structural Growth in Global HNB and E-Vapor Markets
Smoore posted record-high Q3 2025 revenue, driven by growth in both HNB and e-vapor segments, reflecting ongoing expansion of the global next-generation tobacco industry amid compliance and structural upgrades.
Oct.12
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
UK's E-Cigarette Approvals: FREEMAX Products Authorized as Pod Approvals Plummet Over 80% (Sept. 15-21)
UK's E-Cigarette Approvals: FREEMAX Products Authorized as Pod Approvals Plummet Over 80% (Sept. 15-21)
he UK's MHRA has updated its database, adding 317 e-cigarette registrations between September 15 and 21. The new listings feature devices from major brands like IVG and LOST MARY, along with updates for products such as JUUL2 and FREEMAX.
Sep.22